Podcasts about healthcare epidemiology

Join DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard as she reviews the recent article published in Antimicrobial Stewardship & Healthcare Epidemiology titled: “(Re)Moving the Needle: A Retrospective, Quasi-Experimental Assessment of the Impact of a Treatment Guideline on Oral Antibiotic Prescribing for Orthopedic Infections." She discusses how this study highlights the real-world impact of guideline implementation on shifting antibiotic prescribing practices for bone and joint infections. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40160226/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

This episode of the SHEA Podcast, presented by the SHEA Community Healthcare Epidemiologists and Stewards (CHES) group, explores career paths and professional growth in healthcare epidemiology and infection. Moderator Dr. Katie Passaretti is joined by Dr. Erica Shenoy and Dr. Louann Bruno-Murtha to discuss their career paths, key challenges, and strategies for success in infection prevention. The guests share insights on training for a career in healthcare epi, the biggest IPC challenges they face—staffing shortages, maintaining core practices post-pandemic, and constant disruptions—and how they find support through SHEA, CHES resources, and professional networks. They wrap up with advice for those entering or advancing in the field. Tune in for expert perspectives on thriving in healthcare epidemiology!

We are back with more exciting IDWeek 2024 content. In this episode, Breakpoints hostesses Drs. Erin McCreary, Julie Ann Justo, Jeannette Bouchard, and Megan Klatt highlight more of our favorite sessions and posters at IDWeek, this episode is a must listen if you are an IDWeek nerd like us! References: Perret et al. Application of OpenAI GPT-4 for the retrospective detection of catheter-associated urinary tract infections in a fictitious and curated patient data set. 10.1017/ice.2023.189 Wiemken et al. Assisting the infection preventionist: Use of artificial intelligence for health care–associated infection surveillance. 10.1016/j.ajic.2024.02.007 Leekha et al. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study. 10.1136/bmjqs-2023-016831 Diekema et al. Are Contact Precautions "Essential" for the Prevention of Healthcare-associated Methicillin-Resistant Staphylococcus aureus? 10.1093/cid/ciad571 Martin et al. Contact precautions for MRSA and VRE: where are we now? A survey of the Society for Healthcare Epidemiology of America Research Network. 10.1017/ash.2024.350 Browne et al. Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial. 10.1016/S1473-3099(24)00399-2 Protect trial: Decolonization in Nursing Homes to Prevent Infection and Hospitalization. 10.1056/NEJMoa2215254 Aldardeer et al. Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study. 10.1093/ofid/ofae059 Schmiemann et al. Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial. 10.1136/bmj-2023-076305 Vernacchio et al. Improving Short Course Treatment of Pediatric Infections: A Randomized Quality Improvement Trial. 10.1542/peds.2023-063691 Advani et al. Bacteremia From a Presumed Urinary Source in Hospitalized Adults With Asymptomatic Bacteriuria. 10.1001/jamanetworkopen.2024.2283 Saif et al. Clinical decision support for gastrointestinal panel testing. 10.1017/ash.2024.15 Bekker et al. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. 10.1056/NEJMoa2407001 Montini et al. Short Oral Antibiotic Therapy for Pediatric Febrile Urinary Tract Infections: A Randomized Trial. 10.1542/peds.2023-062598 Nielsen et al. Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark. 10.1016/S2352-4642(24)00133-0 Kaasch et al. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. 10.1016/S1473-3099(23)00756-9 AMIKINHAL: Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. 10.1056/NEJMoa2310307 PROPHY-VAP: Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. 10.1016/S2213-2600(23)00471-X AVENIR: Azithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial. 10.1056/NEJMoa2312093 Thomas et al. Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients. 10.1093/cid/ciad458 Schuster et al. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. 10.1093/cid/ciad534 Mahadeo et al. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. 10.1016/S1470-2045(23)00649-6 Khoury et al. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. 10.1016/j.ajt.2024.04.009 Spec et al. MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial. 10.1093/ofid/ofae010

In the 5 Second Rule podcast by APIC, hosts Lerenza Howard and Kelly Holmes discuss infection prevention and control in the context of hurricanes with professionals, Lori Crow and Cindy Prins. From sharing personal experiences to breaking down the role of infection preventionists in such situations, the podcast covers a wide range of topics - from maintaining food safety during power outages to averting mold growth post-flooding. Listen to the IPC experts shed insights on the crucial role played by IPs and infection prevention measures during a hurricane. Hosted by: Lerenza Howard, MHA, CIC, LSSGB and Kelly Holmes, MS, CIC, FAPIC About our Guests: Cindy Prins, PhD, MPH, CIC, CPH, FSHEA Dr. Cindy Prins is an Associate Professor in the Department of Population Health Sciences, College of Medicine at the University of Central Florida, and is part of the UCF Infectious Disease and Travel Health Initiative. She is an infectious disease epidemiologist whose research focuses on infection prevention and control in both healthcare and non-healthcare settings, and on compliance with vaccine recommendations. Dr. Prins is Board Certified in Infection Control (CIC) and Public Health (CPH) and is a Fellow of the Society for Healthcare Epidemiology of America (FSHEA). Lori Zeringue Crow, MPH, MS, CPH Lori holds a background in both microbiology and public health. After a career as a college microbiology instructor, Lori pivoted her path into public health by going back to school to obtain her MPH. Lori now works in public health emergency preparedness and response at a state health department. In that capacity, Lori is trained to prepare for and respond to all types of hazards that can impact public health. Two of the most common types of hazards her department encounters are hurricanes and flooding. Lori's experience with the devastation that hurricanes can bring is not only professional, but also personal as she has lived most of her life on the Gulf Coast. Lori believes infection prevention plays a role in minimizing the impact hurricanes can have on people. She combines her microbiology and public health background to advocate for the inclusion of infection control in hurricane preparedness and response Further Resources: How to build an emergency kit by Ready.gov General public health messaging before, during, and after hurricanes and floods. Covers food safety, mold, proper care of wounds, safe water, waterborne diseases: CDC Preparedness and Safety Messaging for Hurricanes, Flooding, and Similar Disasters CDC's Safe and Healthy Diapering for Emergency Settings and Shelters fact sheet CDC's Preventing Diarrheal Illness After a Disaster fact sheet  APIC's Infection Prevention and Control for Shelters during Disasters Creating a food safety plan for hurricane season: Foodsafety.gov  2023 APIC Emerging Infectious Diseases Task Force: Infection Prevention and Control for Shelters During Disasters Emergency Water Supply Planning Guide for Hospitals and Healthcare Facilities, 2019

In this episode,  hosts Drs. Temara Hajjat and Peter Lu talk to Dr. Maria Oliva-Hemker about diagnosing and managing Clostridioides difficile (C. diff) in children who have inflammatory bowel disease (IBD). Dr. Oliva-Hemker is the Director of the Division of Pediatric Gastroenterology, Hepatology, and Nutrition and the Stermer Family Professor for Pediatric IBD at the Johns Hopkins University School of Medicine. She is also the Vice Dean for Faculty and the Mary Wallace Stanton Professor for Faculty Affairs. Learning Objectives:Learn how to diagnose Clostridioides difficile, particularly when there is concern about a new IBD diagnosis.Learn how to manage C. diff infection in a patient with known IBD.Learn how to manage recurrent and refractory C. diff infection in a patient with IBD.Link: Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal DiseasesACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsSupport the Show.This episode is eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Join Dr. Joe Szot and his guest, Dr. Karen Brust, as they discuss the available tools for monitoring influenza-like illness and how the data collected contributes to infection control planning. Joseph Szot, MD Associate Dean for CME and Integrative Education Clinical Professor of Internal Medicine University of Iowa Carver College of Medicine Karen Brust, MD Clinical Associate Professor of Internal Medicine - Infectious Diseases University of Iowa Carver College of Medicine Hospital Epidemiologist University of Iowa Hospitals & Clinics Resources:  SHEA - The Society for Healthcare Epidemiology of America Infectious Diseases Society of America CIDRAP - Center for Infectious Disease Research and Policy Financial Disclosures:  Dr. Joseph Szot, Dr. Karen Brust, and the members of the planning committee for Rounding@IOWA have no relevant financial relationships to disclose. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=65956  CME Credit Designation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.25 ANCC contact hour. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)  

Katie Passaretti, MD, is vice president and enterprise chief epidemiologist at Atrium Health. Dr. Passaretti is board certified in Internal Medicine and Infectious Diseases. She is a member of the Society of Healthcare Epidemiology of America. Learn more about Katie here: https://atriumhealth.org/clinical-expert-details/katie-passaretti-md

Episode Notes This week we would like to use the feed to share a great episode of Sara Dong's podcast "Febrile."  Members of our DASON team and the Society for Healthcare Epidemiology of America's antimicrobial stewardship committee celebrate antibiotic awareness week by discussing stewardship teams and an example case.

On a worldwide basis, sepsis causes 20% of all deaths. Connie Schaefer, an LNC, registered nurse. She is also an infection preventionist, describes this huge problem and what's being done to prevent infections in healthcare. Speed of diagnosis and also treatment are essential in order to control and cure a septic condition. This is the primary area that makes a difference in handling this condition. Many obstacles can prevent this. Not noticing sepsis is the first problem, but when samples are taken, the skin must be correctly cleaned in order to prevent contamination. Another issue is poor communication between hospital departments. Connie describes the many variables in diagnosis and treatment of sepsis. In big hospitals, serious conditions are automatically flagged, which enables the providers to respond more quickly. She also describes what are commonly known as superbugs, those which are resistant to most or also all antibiotics. Treating them is challenging, but the greater challenge is to make sure that they don't get out into the larger world. Sepsis is often an issue for medical malpractice, and Connie recommends going through the records very thoroughly, with special emphasis on lab records. This issue is sure to come into your professional life, and the podcast will give you a deeper understanding of the issues involved. Learn more about Liability for Infections in Healthcare Facilities - Connie Schaefer What is the sepsis bundle? What percentage of global deaths does sepsis cause? What role does fast and also accurate communication among departments play in diagnosis and treatment of sepsis? What medical records assume priority for an LNC working on a sepsis case? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. https://youtu.be/oWb04XTmBrE Announcing LNC Success™ Virtual Conference 8 October 26,27 & 28 LNC Success™ is a Virtual Conference 3-day event designed for legal nurse consultants just like you! Pat Iyer and Barbara Levin put together THE first Legal Nurse Consulting Virtual Conference in July 2020. They are back with their 8th all-new conference based on what attendees said they'd find most valuable. This new implementation and networking event is designed for LNCs at any stage in their career. Build your expertise, attract higher-paying attorney clients, and take your business to the next level. After the LNC Success™ Virtual Conference, you will leave with clarity, confidence, and an effective step-by-step action plan that you can immediately implement in your business. Your Presenter of Liability for Infections in Healthcare Facilities - Connie Schaefer Connie has been a Registered Nurse for more than 40 years, in a variety of nursing settings (ICU, ER, Procedural Labs, Hospice, and Home Health Care), most recently in Infection Prevention and Long Term Care. Connie became a Legal Nurse in March 2021. She became certified in May 2021 and began to grow her business one case at a time. After attending two Attorney Conferences as a vendor, Connie began to gain new attorney clients, working in Kansas, Nebraska, Oklahoma, Ohio, and Missouri. With nearly 20 years of working as an Infection Preventionist, Connie worked to manage and mitigate infections in both Hospital and Long Term Care Settings. She was also certified in Infection Prevention first obtaining her CIC in 2012. Connie has presented at several Infection Prevention Conferences, Quality Conferences and did a poster presentation at SHEA (Society of Healthcare Epidemiology of America). Connie enjoys providing motivational talks to healthcare workers to "Remember Your Why" we chose healthcare, to begin with, and how important our role of HCW are to the patients we care for. Connect with Connie www.legalnursesolution.com or on social media. https://www.linkedin.

We discuss One Health in this episode with Professor Tom Riley, using C.difficile as the example of explaining why the concept of One Health is so important.   Tom is a Fellow of the Royal College of Pathologists, the Australian Society for Microbiology, the American Academy of Microbiology, the Society for Healthcare Epidemiology of America and the Faculty of Science of the Royal College of Pathologists of Australasia, and has published over 400 book chapters and refereed publications.

We discuss One Health in this episode with Professor Tom Riley, using C.difficile as the example of explaining why the concept of One Health is so important.   Tom is a Fellow of the Royal College of Pathologists, the Australian Society for Microbiology, the American Academy of Microbiology, the Society for Healthcare Epidemiology of America and the Faculty of Science of the Royal College of Pathologists of Australasia, and has published over 400 book chapters and refereed publications.

In this episode, Martin Kiernan talks to Dr Valeria Fabre, Associate Professor of Medicine at Johns Hopkins University School of Medicine and  Associate Medical Director of the Antimicrobial Stewardship Program and an Associate Hospital Epidemiologist at the Johns Hopkins Hospital. We discuss the recent SHEA position paper on practical aspects of diagnostic stewardship and the use of the diagnostic pathway (ie, ordering, collecting, processing, reporting, and interpreting results of a diagnostic test).   Paper discussed: Fabre V, et al. Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol. 2023;44(2):178-185.  https://doi:10.1017/ice.2023.5   Other recent papers on this subject: Warren BG, et al. Evaluation of hospital blood culture utilization rates to identify opportunities for diagnostic stewardship. Infect Control Hosp Epidemiol. 2023;44(2):200-205. https://doi:10.1017/ice.2022.191 Shallal AB, et al. Role of diagnostic stewardship in reducing healthcare-facility-onset Clostridioides difficile infections. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e53. https://doi:10.1017/ash.2022.305 Morgan DJ, et al. Diagnostic Stewardship to Prevent Diagnostic Error. JAMA. 2023. https://doi:10.1001/jama.2023.1678 Chiotos K, et al. Mixed-methods process evaluation of a respiratory-culture diagnostic stewardship intervention. Infect Control Hosp Epidemiol. 2023;44(2):191-199. https://doi:10.1017/ice.2022.299 Advani SD, et al. Optimizing reflex urine cultures: Using a population-specific approach to diagnostic stewardship. Infect Control Hosp Epidemiol. 2023;44(2):206-209. https://doi:10.1017/ice.2022.315  

In this episode, Martin Kiernan talks to Dr Valeria Fabre, Associate Professor of Medicine at Johns Hopkins University School of Medicine and  Associate Medical Director of the Antimicrobial Stewardship Program and an Associate Hospital Epidemiologist at the Johns Hopkins Hospital. We discuss the recent SHEA position paper on practical aspects of diagnostic stewardship and the use of the diagnostic pathway (ie, ordering, collecting, processing, reporting, and interpreting results of a diagnostic test).   Paper discussed: Fabre V, et al. Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol. 2023;44(2):178-185.  https://doi:10.1017/ice.2023.5   Other recent papers on this subject: Warren BG, et al. Evaluation of hospital blood culture utilization rates to identify opportunities for diagnostic stewardship. Infect Control Hosp Epidemiol. 2023;44(2):200-205. https://doi:10.1017/ice.2022.191 Shallal AB, et al. Role of diagnostic stewardship in reducing healthcare-facility-onset Clostridioides difficile infections. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e53. https://doi:10.1017/ash.2022.305 Morgan DJ, et al. Diagnostic Stewardship to Prevent Diagnostic Error. JAMA. 2023. https://doi:10.1001/jama.2023.1678 Chiotos K, et al. Mixed-methods process evaluation of a respiratory-culture diagnostic stewardship intervention. Infect Control Hosp Epidemiol. 2023;44(2):191-199. https://doi:10.1017/ice.2022.299 Advani SD, et al. Optimizing reflex urine cultures: Using a population-specific approach to diagnostic stewardship. Infect Control Hosp Epidemiol. 2023;44(2):206-209. https://doi:10.1017/ice.2022.315  

Overview: This is Ep. 1 of SHEA's four-part series on Leadership & Management which focuses on common issues and questions that arise when individuals are looking for their first job in healthcare epidemiology(including in public health). Experts will address themes including how to start the job search, what to look for in a job, contract negotiations, and recommended training courses. Speakers: Jennifer Hanrahan, DO Sujan Reddy, MD Clare Rock, MD, MS Moderator: Jessica Howard-Anderson, MD

If you're a practitioner, click Here for ethics credit! https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10092705 Date:     Pediatrics Now Podcast Episode, Friday February 10, 2023 Speakers: Podcast Host Holly Wayment interviews Integrative Medicine and Infectious Disease Doctor Jan Patterson, co-author of the fascinating new book Breath for the Soul: Self-Care Steps to Wellness Texas Medical Board of Ethics This presentation meets the Texas Medical Board criteria for formal continuing medical education involving the study of medical ethics and/or professional responsibility.   FACULTY Jan Patterson, MD, is a Professor of Medicine and Integrative and Infectious Disease Doctor at UT Health San Antonio and University Hospital.   OVERVIEW Pediatrics Now host Holly Wayment discusses with Dr. Jan Patterson  simple ways we can use our breath, movement, nutrition, and spirit to care for ourselves, even during our busy work days, and especially during the toughest of times.  Dr. Patterson talks about some simple things we can do for ourselves that take only a few minutes. Plus, Dr. Patterson  opens up about unimaginable grief—the loss of her son Will and how to thrive with life's greatest challenges. DISCLOSURES Jan Patterson, MD is a professor of Medicine/Infectious Disease and Associate Dean for Quality & Lifelong Learning at The Joe. R and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is a clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society of Healthcare Epidemiology of America. She is a longtime infectious disease consultant to the Southwest Texas Regional Advisory Council (STRAC), has served on the CDC's Healthcare Infection Practices Advisory Committee and has been a consultant to the City of San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and was a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies, NIH Accelerating COVID-10 Therapeutic Interventions and Vaccines studies (ACTIV-6) and a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.   The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.  Planning Committee member Steven Seidner, MD has disclosed he receives funding from Draeger Medical for the Clinical Study to Evaluate the Safety and Effectiveness of the Infinity Acute Care System Workstation Neonatal Care Babylog VN500 Device in High-Frequency Oscillatory Ventilation (HFOV) Mode in Extremely Low Birth Weight (ELBW) Neonates for which he is a co-principal investigator. The relevant financial relationships noted for Dr. Seidner have been mitigated.     The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.   CONTINUING EDUCATION STATEMENTS The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.     The UT Health Science Center San Antonio designates this live activity up to a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.      

This week, Marianna sits down with John Faragon to talk about ID Week, the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP), which took place in October 2022. Learn all about what happened in this episode. --Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=DDT4457) 

In this episode, Dr. Sheliza Halani interviews special guest Dr. Alon Vaisman (Infectious Diseases) on the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).They discuss the definitions of severity of C. difficile, recommendations for current treatment and testing, prophylaxis and surgical management options. Producer and Host: Dr. Sheliza HalaniGuest: Dr. Alon Vaisman (Infectious Diseases)Sound Editing: Dr. Alison LaiSupport the show

Dr. Susan Donelan, Medical Monday Underwritten by https://www.guildhall.org/ (Guild Hall) Stony Brook Medicine's Director of Healthcare Epidemiology, Dr. Susan Donelan joins The Heart of The East End to discuss the global outbreak of Monkeypox, which has, at press time, been found in Nassau and Suffolk Counties. For more information, visit https://www.stonybrookmedicine.edu/ (stonybrookmedicine.edu). Henry Diaz, Music on Mondays Underwritten by http://www.cynthiadaniels.net/ (Monk Music Studios) Henry Diaz of the Shirley musical group The Karpenteers joins Gianna to discuss tomorrow's Folkie Fest In The Field. The unique edition of the local songwriter series will take place from 5:30pm to 8:30pm on Tuesday August 9th at Moriches Field Brewery in Center Moriches. For more information, find Folkie Fest on https://www.facebook.com/folkiefest/ (Facebook here.)

This week on Pharm5: FTC launches investigation into PBMs COVID vaccines coming soon for kids

Just when you think this pandemic is over, it rears it's ugly head again. Host Jessica Swain, System Director of Infection Prevention for Dartmouth Health, talks to Dr. Michael Calderwood about where we are now with COVID-19. Dr. Calderwood is the Chief Quality Officer and an Infectious Diseases physician at Dartmouth Health and he shares his insights on studies shared at the recently concluded Society of Healthcare Epidemiology annual conference. We are all experiencing pandemic fatigue but it is important for us to think about what we can do and to understand how it will take each one of us to get through this. Like always, the information shared in this episode is meant for medical education and should not be considered as medical advice

In this episode recorded at the 2022 SHEA Sprong meeting, Martin Kiernan talks to Dr Dian Baker, Emeritus Professor at California State University, Sacramento, USA. Dian has been a passionate advocate for action against healthcare-onset non-ventilator associated pneumonia (nVHAP) for over 12 years and as ever, it was a personal experience that motivated her to look into this important topic. Apart from the human cost, nVHAP is responsible for use of antibiotics and means huge costs for healthcare systems globally. Some of Dian's key papers are listed here: 1. Baker DL, et al. Prevention practices for nonventilator hospital-acquired pneumonia: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). Infect Control Hosp Epidemiol. 2021:1-2.  http: 2. Quinn B, et al. Non-ventilator health care-associated pneumonia (NV-HAP): Best practices for prevention of NV-HAP. Am J Infect Control. 2020;48(5S):A23-A27.  https://doi.org/10.1016/j.ajic.2020.03.006 3. Giuliano KK, et al. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(3):322-327.  https://doi.org/10.1016/j.ajic.2017.09.005 4. Baker D, et al. Hospital Acquired Pneumonia Prevention Initiative-2: Incidence of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(1):2-7.  https://doi.org/10.1016/j.ajic.2017.08.036 5. Quinn B, et al. Basic nursing care to prevent nonventilator hospital-acquired pneumonia. J Nurs Scholarsh. 2014;46(1):11-19.  https://doi.org/10.1111/jnu.12050

In this episode recorded at the 2022 SHEA Sprong meeting, Martin Kiernan talks to Dr Dian Baker, Emeritus Professor at California State University, Sacramento, USA. Dian has been a passionate advocate for action against healthcare-onset non-ventilator associated pneumonia (nVHAP) for over 12 years and as ever, it was a personal experience that motivated her to look into this important topic. Apart from the human cost, nVHAP is responsible for use of antibiotics and means huge costs for healthcare systems globally. Some of Dian's key papers are listed here: 1. Baker DL, et al. Prevention practices for nonventilator hospital-acquired pneumonia: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). Infect Control Hosp Epidemiol. 2021:1-2.  http: 2. Quinn B, et al. Non-ventilator health care-associated pneumonia (NV-HAP): Best practices for prevention of NV-HAP. Am J Infect Control. 2020;48(5S):A23-A27.  https://doi.org/10.1016/j.ajic.2020.03.006 3. Giuliano KK, et al. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(3):322-327.  https://doi.org/10.1016/j.ajic.2017.09.005 4. Baker D, et al. Hospital Acquired Pneumonia Prevention Initiative-2: Incidence of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(1):2-7.  https://doi.org/10.1016/j.ajic.2017.08.036 5. Quinn B, et al. Basic nursing care to prevent nonventilator hospital-acquired pneumonia. J Nurs Scholarsh. 2014;46(1):11-19.  https://doi.org/10.1111/jnu.12050

Today's episode features Professor Allen Cheng, the Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health, Professor of Infectious Diseases Epidemiology at Monash University and the Chair of the Advisory Committee on Vaccines to the Therapeutic Goods Administration and an infectious diseases physician. He is also known to many for his year-long secondment as the Deputy Chief Health Officer of Victoria from July 2020 – June 2021. As Professor Cheng says in today's episode, he has a “very specific skill set.” An infectious diseases clinician specialising in respiratory infections and flu vaccine effectiveness, he was expertly qualified to lead Victoria's public health response to the COVID-19 pandemic. Professor Cheng talks about the challenges of transitioning from a researcher and clinician to public health practitioner, and the lessons he learnt in the process. He advocates for innovative approaches to public health preparedness, like a “public health reservist core,” and talks about how governments can and should effectively buy and use vaccines and COVID treatments. It's a fascinating discussion and we hope you join the conversation @CentreHealthSec

In this episode of the ICHE Podcast, Editor-in-Chief, David P. Calfee, MD, MS, interviews Michael Klompas, MD and Dian Baker, PhD on their work on the topic of nonventilator hospital-acquired pneumonia. Drs. Calfee, Klompas, and Baker discuss two papers from the March issue of ICHE, as well as several recent publications. Article list below. Baker DL, Giuliano KK. Prevention practices for nonventilator hospital-acquired pneumonia: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). ICHE 2022;43(3): Klompas M, Baker DL. Finding the balance between overtreatment versus undertreatment for hospital-acquired pneumonia. ICHE 2022;43(3): Munro SC, Baker DL, Giuliano KK, … Klompas M. Nonventilator hospital-acquired pneumonia. A call to action: recommendations from the National Organization to Prevent Hospital-Acquired Pneumonia (NOHAP) among nonventilated patients. ICHE 2021;42(8-August): 991-996 Lacerna CC, et al. A successful program preventing nonventilator hospital-acquired pneumonia in a large hospital system. ICHE 2020;41:547-552.

A Look at New Weight Loss Meds and Weight Related Stigma: The Takeaway spoke with Emma Court, health reporter at Bloomberg News about this new class of weight loss drugs. And maybe you've noticed there is more than a little fat-shaming going on around Covid-19, obesity, and mortality. We also spoke about this with Paula Atkinson, a body liberation psychotherapist and professor at George Washington University, where she teach a course about body justice called Weight and Society. Masking 101: The Takeaway spoke to Dr. Lisa  Maragakis, Professor of Medicine at the Johns Hopkins University School of Medicine and Senior Director of Healthcare Epidemiology and Infection Prevention with the Johns Hopkins Health System, about the latest on masking, which masks are most effective, and more. Why Some Star Athletes Refuse The Vaccine And Get Away With It: We speak with sportswriter Kavitha Davidson about why this mentality from these players matters in the sports world and beyond. Navarro is Back on the Mat for Season 2 of Cheer: We speak with the director and executive producer of Cheer, Greg Whiteley, about what to expect this season and why the docuseries has us all cheering for the cheerlebrities of Navarro. For transcripts, see individual segment pages.

In this episode of Curbside Consults, we examine the latest guidelines on the management of Clostridiodes difficile (C. difficile) infection. This year, updated guidelines were developed by the Infectious Diseases Society of America and Society for Healthcare Epidemiology of America, as well as the American College of Gastroenterology. Here, we...

On this episode, we review the 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults published by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).  Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Drs. Molly Sinert and Jon Furuno join Dr. David Ha (@DHpharmd) to discuss the prevalence of antibiotic use and its harms and benefits in reducing suffering and providing comfort during end-of-life care. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/ References: Sinert et al. Guidance for Safe and Appropriate Use of Antibiotics in Hospice Using a Collaborative Decision Support Tool. Accessed October 6, 2021. https://oce-ovid-com.laneproxy.stanford.edu/article/00129191-202008000-00005/HTMLA Albrecht JS, McGregor JC, Fromme EK, Bearden DT, Furuno JP. A Nationwide Analysis of Antibiotic Use in Hospice Care in the Final Week of Life. Journal of Pain and Symptom Management. 2013;46(4):483-490. doi:10.1016/j.jpainsymman.2012.09.010 Furuno JP, Noble BN, Fromme EK. Should we refrain from antibiotic use in hospice patients? Expert Review of Anti-infective Therapy. 2016;14(3):277-280. doi:10.1586/14787210.2016.1128823 Servid SA, Noble BN, Fromme EK, Furuno JP. Clinical Intentions of Antibiotics Prescribed Upon Discharge to Hospice Care. Journal of the American Geriatrics Society. 2018;66(3):565-569. doi:10.1111/jgs.15246 Gaw CE, Hamilton KW, Gerber JS, Szymczak JE. Physician Perceptions Regarding Antimicrobial Use in End-of-Life Care. Infection Control & Hospital Epidemiology. 2018;39(4):383-390. doi:10.1017/ice.2018.6 Broom J, Broom A, Good P, Lwin Z. Why is optimisation of antimicrobial use difficult at the end of life? Internal Medicine Journal. 2019;49(2):269-271. doi:10.1111/imj.14200 Kwon KT. Implementation of Antimicrobial Stewardship Programs in End-of-Life Care. Infect Chemother. 2019;51(2):89-97. doi:10.3947/ic.2019.51.2.89 Datta R, Topal J, McManus D, et al. Perspectives on antimicrobial use at the end of life among antibiotic stewardship programs: A survey of the Society for Healthcare Epidemiology of America Research Network. Infection Control & Hospital Epidemiology. 2019;40(9):1074-1076. doi:10.1017/ice.2019.194 Lopez S, Vyas P, Malhotra P, et al. A Retrospective Study Analyzing the Lack of Symptom Benefit With Antimicrobials at the End of Life. Am J Hosp Palliat Care. 2021;38(4):391-395. doi:10.1177/1049909120951748 Ito H. Antibiotics in end-of-life care: What is the driving factor? Infectious Diseases Now. Published online July 7, 2021. doi:10.1016/j.idnow.2021.07.003 Kates OS, Krantz EM, Lee J, et al. Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With Cancer. Open Forum Infectious Diseases. 2021;8(8). doi:10.1093/ofid/ofab361 Hickman SE, Nelson CA, Moss AH, Tolle SW, Perrin NA, Hammes BJ. The consistency between treatments provided to nursing facility residents and orders on the physician orders for life-sustaining treatment form. J Am Geriatr Soc. 2011; 59(11): 2091–2099. doi:10.1111/j.1532-5415.2011.03656.x. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, Volume 62, Issue 10, 15 May 2016, Pages e51–e77, https://doi.org/10.1093/cid/ciw118

Overview: This episode reviews the current news updates of this pandemic as well as recently updated guidelines and medical literature. In addition, our moderator, Dr. David Banach, speaks with Roza Tammer, Infection Control Epidemiologist at Oregon Health Authority, about the ways healthcare epidemiologists in settings like university hospitals interact with their state public health epidemiologists. They discuss how they each work as epidemiologists in their roles, how they intersect with one another, what COVID has taught them, and ways to work together after the pandemic. Speakers: - Roza Tammer, MPH, CIC - David Banach, MD, MPH (moderator) - Jennifer Hanrahan, DO, MSc (news update) Sources from news update: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html https://www.nejm.org/doi/full/10.1056/NEJMoa2108891?query=featured_home https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782982 Do you have feedback for our podcast? Topic or speaker ideas? Let us know at https://learningce.shea-online.org/content/shea-podcast-feedback

Why is Christiana Care now mandating vaccines for all employees? How safe is the vaccine in real world use? Dr. Marci Drees is the Chief Infection Prevention Officer and hospital epidemiologist for Christiana Care. She is a national expert on infectious diseases, healthcare-associated infections, and vaccines. Dr. Drees chairs the Education Committee of the Society for Healthcare Epidemiology of America (SHEA), and serves as SHEA's liaison to the CDC's Advisory Committee on Immunization Practices (ACIP). She is board certified in internal medicine and infectious diseases.

Connie Savor Price, MD is the Chief Medical Officer (CMO) at Denver Health and a Professor of Medicine in the Division of Infectious Diseases at the University of Colorado School of Medicine. Prior to becoming the CMO, she served as the Chief of Infectious Diseases and the Medical Director of Infection Control and Prevention at Denver Health for 13 years. Dr. Price is board-certified in internal medicine, infectious diseases, and medical microbiology. Her research and clinical interest focus on healthcare epidemiology and methods to prevent and rapidly detect emerging and antimicrobial-resistant infections. Dr. Price has a track record of successful federal funding as a Principal Investigator from the National Institutes of Health, the Department of Defense, and the Agency for Healthcare Research and Quality. She has published >75 manuscripts and delivered >175 lectures on the prevention of healthcare-associated infectious diseases and related topics. She is active in the Infectious Diseases Society of America, served in an elected position on the Board of Directors of the Society of Healthcare Epidemiology of America, and a past chair of the American Society for Microbiology section on Healthcare Epidemiology. Dr. Price was the physician representative on the inaugural Colorado Healthcare-Associated Infections advisory committee for public reporting of healthcare-associated infections for Colorado. She has recognized expertise in outbreak management and has served as a consultant to public health authorities around the world on control of emerging infections, specifically MERS and SARS, as well as Ebola preparedness. Connect with Dr. Connie Price Website | Twitter Follow Heidi on Social Media! Instagram | Facebook | Twitter | LinkedIn | Spotify About Heidi As a homegrown Coloradan with a passion for keeping the spirit of our state alive and well, I started this podcast to bring the people of Colorado together to celebrate the amazing state we call home! Come along on this journey with me as I travel across our state in my vintage RV, interviewing folks who embody the true spirit of the Rocky Mountains. From the front range to the mile-high city, to the mountain towns and the Wild West of southern Colorado, we'll celebrate the history, beauty, and Coloradans that make this place the colorful state it is! Each week, you'll meet the people trailblazing the way for an even more colorful future for us all, and who are making a huge difference along the way. Visit heidiganahl.com to learn more about the podcast and where we are headed! Submit a guest to Heidi's Colorful Colorado! CLICK HERE!

On this episode of “Beyond the White Coat,” Rosha McCoy, MD, AAMC senior director for advancing clinical leadership and quality, talks with health care providers and experts to debunk common myths and share accurate information about the COVID-19 vaccines as part of the nation’s efforts to increase vaccinations and end the pandemic.Episode GuestsEaric Bonner, MD, is an internal medicine physician at Vidant Internal Medicine in Edenton, North Carolina. He also works at Vidant Chowan Hospital as a hospitalist and at the Brody School of Medicine at East Carolina University as an assistant professor of internal medicine. Currently, he serves as the medical director for ambulatory quality and patient safety; the regional medical director for the Vidant practices in Bertie, Chowan, and Perquimans counties; and director of continuing medical education for Vidant Chowan Hospital. He was formerly the hospitalist medical director and chief of medicine for Vidant Chowan Hospital. In his practice, he continues to teach students and residents from North Carolina’s medical, nursing, and physician assistant schools.Mamie Williams, MPH, is the director of nurse safety and well-being at Vanderbilt University Medical Center. She is currently completing a PhD in nursing from the University of Kansas. At present, she serves as the co-chair of the VUMC African American Employee Resource Group and the VUMC Racial Equity Task Force. Ms. Williams is also an advisory board member for the American Nurses Association’s Healthy Nurse, Healthy Nation national initiative. In her spare time, Ms. Williams is an avid gardener.  Ross McKinney Jr., MD, is the AAMC’s chief scientific officer, an infectious disease specialist, and a member of the Duke University faculty for over 30 years. During his time at Duke, he was director of the Division of Pediatric Infectious Diseases, vice dean for research at Duke University School of Medicine, and director of the Trent Center for Bioethics, Humanities, and History of Medicine. Dr. McKinney leads the AAMC’s programs that support medical research and the training of physician-scientists in academic medicine.Zanthia Wiley, MD, is the director of antimicrobial stewardship at Emory University Hospital Midtown. She completed medical school at the University of Alabama School of Medicine and both her Internal Medicine residency and Infectious Diseases fellowship at Emory. She has the unique experience of having worked as an academic hospitalist at Emory for 10 years prior to pursuing a career in infectious diseases. Dr. Wiley is dedicated to education and received the Jonas A. Shulman Teacher of the Year Award for 2018-2019, which is awarded yearly by the Emory Infectious Diseases fellows to a faculty member for excellence in teaching. She is a member of the Society for Healthcare Epidemiology of America Education Committee and the Infectious Diseases Society of America Medical Education Community of Practice. Dr. Wiley is the joint principal investigator on an institutional Woodruff Health Sciences Center COVID-19 Center for Urgent Research Engagement Award assessing “Clinical Characteristics, Outcomes, and Predictors of Readmission in Hospitalized COVID-19 Patients at Eight Atlanta Hospitals.” She is an investigator in several clinical trials, including the large national Adaptive COVID-19 Treatment Trial studies, and she is a co-investigator in the Emory Vaccine and Treatment Evaluation Unit. Dr. Wiley is a member of the Diversity, Equity, and Inclusion Council in Emory University School of Medicine's Department of Medicine and the Emory Collaborative Community Outreach and Health Disparities Research Initiative, and she serves as the physician lead of the Emory Healthcare COVID-19 Treatment Guidance Committee. She has given numerous talks on COVID-19 disparities on a local, regional, and national level and is dedicated to educating patients, their families, health care providers, and the community on the importance of COVID-19 vaccination.Credits:Hosted by Rosha McCoy, MD, AAMC senior director for advancing clinical leadership and quality.Produced by Stephanie Weiner, AAMC director of digital strategy and engagement.Recorded and edited by Laura Zelaya, AAMC production manager.With special contributions from Michelle Zajac, AAMC digital copy editor; Sholape Oriola, AAMC video specialist; John Buarotti, AAMC senior media relations specialist; and Mikhaila Richards, AAMC senior digital content strategist.You Might Also Be Interested In:“Convincing Rural Residents to Get a COVID-19 Vaccine” AAMCNews, April 15, 2021 More episodes in the “VaccineVoices” podcast seriesAAMC resources for media covering COVID-19 vaccination efforts Myths and facts about COVID-19 vaccines (CDC) 

What comes to mind when you hear the word, “microbes”? If your first thought is bacteria, you may also correlate that with sickness. Surprisingly, that is not always the case. Join us and our guests, Dr. Salah Qutaishat and Dr. Timothy Wiemken, for a discussion on the importance of a well-balanced microbiome through the lens of two of their great loves: yogurt and beer. This episode exposes the microbial parallel between a brewery and a hospital, and the necessity of microbes in our day-to-day health. Hosted by: Silvia Quevedo, CAE About our Guests: Salah S. Qutaishat, PhD, CIC, FSHEA, FAPIC Salah Qutaishat, PhD, is currently a consultant in infection prevention and healthcare epidemiology. Most recently, he held the position of system director of Infection Prevention at Munson Healthcare. He is dedicated to helping healthcare organizations prevent healthcare-associated infection and antimicrobial resistance through automation and process simplification. Dr. Qutaishat received his PhD in microbiology from the SUNY at Buffalo, an MS in medical biology from Long Island University, and a BS in Biology from the University of Jordan. For the past two decades he held several positions in infection prevention and healthcare epidemiology. He is an expert in infection prevention, prevention of microbial resistance and healthcare informatics. Dr. Qutaishat is also certified in infection control (CIC) and is a fellow of the Society of Healthcare Epidemiology of America (FSHEA). He was on the clinical faculty at SUNY at Buffalo and University of Wisconsin at La Crosse. He is a member of several professional societies including the Society for Healthcare Epidemiology of America (SHEA), Association for Professionals in Infection Control and Epidemiology (APIC), Infectious Diseases Society of America (IDSA), American Society for Microbiology (ASM). Dr. Qutaishat has published numerous papers in peer-reviewed journals, he is also a reviewer for both APIC and SHEA journals. He also presented clinical findings at national and local meetings. Timothy L. Wiemken, PhD, MPH, FAPIC, FSHEA, CIC Dr. Timothy Wiemken is an Associate Professor in the Saint Louis University School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, Allergy, and Immunology. He is the Director of Infectious Diseases Epidemiology for SSM Health Saint Louis University Hospital, the Director of Data Science and Epidemiology in the Institute for Vaccine Science and Policy, and the Director of the Systems Infection Prevention Center at Saint Louis University. Dr. Wiemken has a doctorate in Public Health from the University of Louisville, a master’s degree in Epidemiology from Saint Louis University, and has a bachelor’s degree in microbiology and molecular biology from Southern Illinois University. He was previously an infection preventionist at the University of Louisville Hospital and the Hospital Epidemiologist for the Robley Rex Veterans Affairs Medical Center in Louisville, KY. He has been certified in infection prevention and control since 2008 and is a fellow of both the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA). He is active with APIC and the SHEA, serving on many national committees. He has authored and co-authored numerous guidelines and book chapters on infectious diseases and infection prevention, and nearly 200 peer-reviewed journal articles, book chapters, and national/international guidelines related to infectious disease epidemiology. His research currently focuses on pneumonia, influenza, emerging respiratory pathogens, data science in healthcare, and healthcare-associated infections.

Guest: Maria I. Vazquez Roque, M.D. (@MVazquezRoqueMD)  Host: Darryl S. Chutka, M.D. (@ChutkaMD)  Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There's been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There's now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We'll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation.  Additional resources:  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): https://doi.org/10.1093/cid/cix1085  Specific topics discussed: The typical presentation of C. difficile infection Patients who are at increased risk for a C. difficile infection Laboratory tests to order to confirm a case of C. difficile infection Treatment options for C. difficile infection including fecal transplantation Potential benefit of probiotics for preventing a C. difficile infection Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

In this episode, we continue our RPA for Healthcare series with Anna Twomey, Blue Prism's Senior Solutions Advisor for Healthcare Americas and KeyMark's Sam Whitten, Director of RPA Sales. We talk through how RPA can help epidemiologists with the current landscape of COVID-19 vaccine distribution and contact tracing. For more information on RPA for Healthcare, please visit our website at https://www.keymarkinc.com/rpa/

IDSA Board member John Lynch, M.D., FIDSA, & SHEA/IDSA member Erica Shenoy, M.D., FIDSA discuss how to create safe environments across medical facility departments while treating COVID-19 patients. This episode was produced in partnership with the Society for Healthcare Epidemiology of America.

There is a reason we like to open windows or get outside for some "fresh air." Air quality and ventilation are a big deal when we try to stop the spread of viruses that can travel in the air. It can be daunting and scary, but fear not, because Dr. Hilary Babcock and Kate Gase, infection preventionist, break down the science of airborne and droplet disease transmission. In this episode, they inform us on the factors that determine how infectious a virus or bacteria may be given various environmental factors. They emphasize the importance of following what science tells us about preventing the spread of diseases. Hosted by: Silvia Quevedo About our Guest(s): Dr. Hilary Babcock, MD, MPH Dr. Hilary Babcock is a Professor of Medicine in the Infectious Diseases division at Washington University School of Medicine in St Louis and Medical Director of the Infection Prevention and Epidemiology Consortium and Occupational Infection Prevention for BJC HealthCare, a multi-hospital system in St Louis. She is also an associate hospital epidemiologist at Barnes Jewish Hospital. She is a fellow of the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). She is the immediate past-President of SHEA. She has been a member of HICPAC (CDC’s Healthcare Infection Control Practices Advisory Committee) since 2013 and is currently co-chair of the committee. She is a CDC funded investigator studying healthcare-associated infections and respiratory viral infections in healthcare settings. Kathleen Gase, MBA, MPH, FAPIC, CIC Kathleen (Kate) Gase is the Director of Patient Safety, Quality and Care Coordination at Barnes-Jewish St. Peters and Progress West Hospitals in the St. Louis, MO area. She has previous work experience with BJC HealthCare, the New York State Department of Health and Memorial Sloan-Kettering Cancer Center. Kate earned her undergraduate degree at Washington University in St. Louis, her Master’s in Public Health at Hunter College in New York City, and returned to Wash U to complete her MBA. She is certified in Infection Prevention and Epidemiology, a Fellow of the Association for Professionals in Infection Control and Epidemiology (APIC) and is currently serving on the APIC Board of Directors.

Jenny Rae sits down with Kristy Weinshel (Executive Director at The Society for Healthcare Epidemiology of America) and Dr. Kavita Trivedi (Managing Director of Trivedi Consults) for an engaging conversation around independent consulting. The interview covers a lot of ground, including:How do you start a consulting practice from a specific expertise?How do you know where the line is between giving away information for free vs charging for your expertise?What do you expect to change in the healthcare consulting industry in the next 5 years?West Coast or East Coast: which is better?And more!Enjoy this fantastic conversation with two of the foremost subject matter experts in the healthcare consulting industry.SHEA website: www.shea-online.orgTrivedi Consults website: www.trivediconsults.comFind Kristy on LinkedIn: www.linkedin.com/in/kristy-weinshel-mba-cae-18ab251Find Dr. Trivedi on LinkedIn: www.linkedin.com/in/kavita-k-trivedi-488b6a4Find Dr. Trivedi on Twitter: @kavitaktrivediLearn more about MC's Corporate Training packages: tinyurl.com/mc-corporateContact MC: team@managementconsulted.comPartner with MC: tinyurl.com/mcpartnership

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between Healthcare Epidemiology and Hospital Medicine in a discussion with the Society for Critical Care Medicine (SCCM). Speakers: - Lewis J. Kaplan, MD, FACS, FCCP, FCCM - Mayar Al Mohajer, MD (moderator) Special thank you to our partnering organization for their collaboration on this podcast series, the Society for Critical Care Medicine (SCCM): The Society of Critical Care Medicine (SCCM) is the largest nonprofit medical organization dedicated to promoting excellence and consistency in the practice of critical care. Visit the SCCM COVID-19 Rapid Resource Center, https://www.sccm.org/COVID19RapidResources/Home, to access hundreds of resources related to the pandemic. Non-ICU clinicians who could benefit from critical care training to respond to COVID-19 during a surge response, can find training at sccm.org/covid19.

Guests:  • Sara Keller, MD, MPH, MSHP – Moderator • Dawn Berndt, DNP, RN, CRNI®  Abstract:  We're all in this Together: COVID-19 Allies in Infection Prevention We've joined the Society for Healthcare Epidemiology of America (SHEA) for an episode of their Allies in Infection Prevention Podcast. This podcast series focuses on collaborative efforts, as well as opportunities for different disciplines to address and confront the COVID-19 pandemic. Take a listen to Working together to address COVID-19 Challenges. Resources: Society for Healthcare Epidemiology of America (SHEA). https://www.shea-online.org/  Infusion Nurses Society (INS). www.ins1.org 

Collaboration During COVID-19. Infusion Nurses Society in Collaboration with Society for Healthcare Epidemiology of America (SHEA). In this episode, Dr. Sara Keller and Dawn Berndt discuss a collaboration between Hospital Epidemiology and Infusion Nursing.

Join us with our Guest; Dale N. Gerding, MD, MACP, FIDSA, FSHEA. Dr. Gerding is a Research Physician at the Edward Hines Jr. VA Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois (retired). Dr. Gerding's long and distinguished career includes past president of the Society for Healthcare Epidemiology of America, past chair of the antibiotic resistance committee of SHEA and past chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He was the recipient of the 2013 William S. Middleton Award. The Middleton Award is the highest honor awarded annually by the Biomedical Laboratory Research and Development Service to senior VA biomedical research scientists. Dr. Gerding will be discussing C. diff. as a bacterium, the infection on the Epidemiology level in prevention, treatments, with the research and development of Clinical Trials. This super bug history is a stellar beginning

Join us with our Guest; Dale N. Gerding, MD, MACP, FIDSA, FSHEA. Dr. Gerding is a Research Physician at the Edward Hines Jr. VA Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois (retired). Dr. Gerding's long and distinguished career includes past president of the Society for Healthcare Epidemiology of America, past chair of the antibiotic resistance committee of SHEA and past chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He was the recipient of the 2013 William S. Middleton Award. The Middleton Award is the highest honor awarded annually by the Biomedical Laboratory Research and Development Service to senior VA biomedical research scientists. Dr. Gerding will be discussing C. diff. as a bacterium, the infection on the Epidemiology level in prevention, treatments, with the research and development of Clinical Trials. This super bug history is a stellar beginning

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between Pharmacy and Healthcare Epidemiology in a discussion with the American Society of Health-System Pharmacists (ASHP). Speakers: - Katherine Reisbig, PharmD, BCPS - Whitney Buckel, PharmD, BCPS (moderator)

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between the representatives of Healthcare Epidemiology and Infectious Diseases in a discussion with the National Foundation for Infectious Diseases (NFID). Speakers: - William Schaffner, MD, NFID Medical Director, Past President of SHEA - Sara Cosgrove, MD, MS, Past President of SHEA (moderator)

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between Healthcare Epidemiology and Hospital Medicine in a discussion with the Society of Hospital Medicine (SHM). Speakers: - Joseph Sweigart, MD - Valerie Vaughn, MD, MSc (moderator)

Vol 212, Issue 9: 18 May, 2020. Professor Allen Cheng is the Director of Infection Prevention and Healthcare Epidemiology at Alfred Health. Professor Deb Williamson is the Director of Clinical Microbiology at the Royal Melbourne Hospital. They discuss the latest COVID-19 news and projections. With MJA news and online editor, Cate Swannell.

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between Healthcare Epidemiology and Anesthesiology in a discussion with the American Society of Anesthesiologists (ASA). Speakers: - Grant Lynde, MD, MBA - Marci Drees, MD, MS, FACP, DTMH (moderator)

We’re all in this Together: COVID-19 Allies in Infection Prevention This podcast series will focus on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. This episode focuses on collaborations between Healthcare Epidemiology and Nephrology in a discussion with the American Society of Nephrology (ASN) and the Centers for Disease Control and Prevention (CDC). Speakers: - Alan S. Kliger, MD - Shannon Novosad, MD, MPH - Waleed Javaid, MD (moderator)

In literally minute-by-minute, life and death situations, healthcare providers around the world are putting their own lives at risk as they answer the call to treat overwhelming numbers of Coronavirus patients. The situation is nowhere more challenging than in New York State, Long Island and here in Stony Brook, where medical professionals have been keeping pace with the surge day by day. On this episode of “Beyond the Expected," hosted by Interim President MIchael Bernstein, Stony Brook University Hospital attending physicians share their personal experiences of being infected by, and recovering from, COVID-19, in this environment, and Stony Brook University Hospital's Medical Director of Healthcare Epidemiology provides her expert opinions on how to stop the spread among patients and providers. Susan Donelan, MD, FSHEA, Medical Director, Healthcare Epidemiology Department; Hospital Epidemiologist; Assistant Professor, Infectious Diseases and Medical Director, Regional Training Center, MARO Region Susan Donelan has a strong clinical expertise in infectious diseases such as Lyme Disease and West Nile Virus, hospital-acquired infections, and MRSA. She has an interest in emerging infectious diseases, and her Ebola care plan is adaptable for patients who may have diseases like MERS-CoV and avian influenza. She has certified training in pandemic planning and preparedness, and trained for a week in Anniston, Alabama at the Center for Domestic Preparedness, with a certification in Healthcare Leadership and Decision Making. Dr. Donelan will share how all of this training and experience is being put to work in our current pandemic crisis to help prevent the occurrence, and spread, of COVID-19 among patients and the healthcare professionals treating them. Kimberly Noel, MD MPH, Stony Brook Medicine Telehealth Director; Deputy Chief Medical Information Officer; Patient Centered Medical Home Chief Quality Officer, Family Medicine; Occupational and Employee Health & Wellness Physician; Clinical Assistant Professor of Family, Population & Preventive Medicine Dr. Noel is a physician, published researcher, and telehealth specialist. She serves as the Director of Stony Brook Medicine Telehealth and the Deputy Chief Medical Information Officer and Chief Quality Officer of Family Medicine's PCMH. She devises telehealth strategy, implementation and policy solutions in collaboration with key stakeholders at Stony Brook and co-leads the Telehealth Workgroup, reporting to the Chief Information Officer. She is an occupational health physician, and practices clinically caring for Stony Brook employees. Beyond Stony Brook, Dr. Noel is an appointee to the New York State Department of Health Regulatory Modernization Initiative Telehealth Advisory Committee. She is leading a program for the American Telemedicine Association 2020 Conference for Telehealth Accessibility for persons with disabilities. James Vosswinkel, MD, FACS, Chief, Trauma, Emergency Surgery and Surgical Critical Care; Medical Director, Trauma Center Surgical ICU, Stony Brook Medicine; and Lillian and Leonard Schneider Endowed Professor in Trauma Surgery James “Voss” Vosswinkel's specialties include surgical management of injured patients in all aspects of traumatology. That includes management of diseases of the gastrointestinal and endocrine systems; treatment of soft tissue disease; repair of hernias; appendectomy; cholecystectomy; laparoscopic surgery; and pre- and post-operative critical care of adult surgical patients. Before and during this Coronavirus pandemic, he has been leading efforts to increase our Intensive Care Unit (ICU) capacity; collaborate with medical professionals locally, across the country and globally to share experiences and best practices; and develop innovative ways to treat patients in trauma under unimaginably challenging circumstances.

Tom’s guest today is Martin O’Malley, who served as the mayor of Baltimore from 1999 to 2007, and as the 61st Governor of Maryland, from 2007 to 2015. In 2016, he sought the Democratic nomination for president of the United States. For decades, an argument about the fundamental role of government has raged between those on the political right who often think of government as invasive and overbearing, and those on the left who see social programs and other functions of government as a fundament of American society. As political leaders confront the COVID-19 pandemic at the local, state and federal levels, the need for governmental intervention in times of crisis is acknowledged by those of every political stripe. Drawing on his own experience as a Maryland chief executive, Martin O’Malley has written a book about leadership, and how executives at all levels of government can employ best practices to improve outcomes in violence reduction, education, the environment, and a host of other issues. The book is called Smarter Government: How to Govern for Results in the Information Age. You can explore its central themes at smartergovernment.com. Martin O’Malley joins Tom on the phone from his home in Baltimore. In today's conversation, Gov. O'Malley mentioned his interest in the urgent appeal, sent out by the directors of Emergency Management and Healthcare Epidemiology at Johns Hopkins Medicine, for donations of Powered Air Purifying Respirators (PAPRs), a critically important type of personal protective equipment (PPE) for health workers treating coronavirus patients. If you can help provide this or other PPE resources, please contact George Lavdas, Hopkins' Senior Director for Supply Chain Transformation, by email at glavdas@jhni.edu, or by cell at: (443) 766-0758.

Kelly A Cawcutt MD is back for her 2nd interview in as many weeks to give us the latest Coronavirus COVID-19 updates from the front lines. Dr. Cawcutt is an infectious disease and critical care specialist who outlines the situation facing american hospitals and caregivers, the importance of social distancing, and how events are expected to unfold over the coming weeks. How long will this virus impact our communities? Will our hospitals have enough beds? Will there be a second wave? Should people take any supplements? Should doctors administer HIV medication to patients? These and many more questions are discussed in this follow-up interview to GetHealthy360's first podcast with Dr. Cawcutt. Kelly Cawcutt, MD, MS, FACP is an assistant professor of medicine and is board certified in Critical Care Medicine and Infectious Diseases. She is an Assistant Professor of Medicine and Associate Director of Infection Control. She holds national positions with the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, and the Society of Critical Care Medicine. Dr. Cawcutt is also a physician member of the UNMC biocontainment unit. For more information, Dr. Cawcutt can be found on social media: Twitter: @kellycawcuttmd and @unmc_id Instagram: @kellycawcuttmd

Two doctors get real about the Coronavirus in this episode of the GetHealthy360 podcast. When would they stop sending their kids to school? Would they stockpile food at home? What would they do if one of their children came down with the disease. And what went so wrong on the Diamond Princess cruisehip in Japan? Kris Ferguson MD interviews Kelly A Cawcutt MD. Kelly Cawcutt, MD, MS, FACP is an assistant professor of medicine and is board certified in Critical Care Medicine and Infectious Diseases. She is an Assistant Professor of Medicine and Associate Director of Infection Control. She holds national positions with the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, and the Society of Critical Care Medicine. Dr. Cawcutt is also a physician member of the UNMC biocontainment unit. For more information, Dr. Cawcutt can be found on social media: Twitter: @kellycawcuttmd and @unmc_id Instagram: @kellycawcuttmd

Welcome to the ICHE Podcast! ICHE is the official journal for the Society for Healthcare Epidemiology of America. In each episode of The ICHE Podcast, we interview authors of articles recently published in the journal.

Dr. Jasmine Marcelin is an infectious disease doctor at the University of Nebraska Medical Center.  How did a doctor from Antigua end up in Nebraska?  Through Canada, of course!  It is an interesting story that she uses to educate us about some of the challenges and stigmas that international medical graduates face in order to practice medicine in the US.  Dr. Marcelin is an Assistant Professor of Medicine, Co-Director of Digital Innovation & Social Media Strategy and Associate Medical Director of Antimicrobial Stewardship and Infection Prevention & Control at University of Nebraska Medical Center & Nebraska Medicine. Her Antimicrobial Stewardship interests include diagnostic stewardship and ambulatory stewardship. She is a member of the Society for Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA). Dr. Marcelin is a member of several national medical society committees including the IDSA Medical Student Scholarship Committee, the Inclusion, Diversity, Access & Equity Taskforce, SHEA Awards committee and SHEA Journal Club Committee. She is a passionate advocate for gender and racial/ethnic diversity, inclusion and equity in medicine and contributes to Faculty Development efforts related to diversity & inclusion and social media for healthcare professionals. Dr. Marcelin received her medical degree from American University of Antigua College of Medicine and completed her Internal Medicine Residency & Infectious Diseases Fellowship at Mayo Clinic in Rochester, MN.  You can follow her work on twitter @DrJRMarcelin and on LinkedIn.   Find this and all episodes on your favorite podcast platform at PhysiciansGuidetoDoctoring.com Please be sure to leave a five star review, a nice comment and SHARE!!!

Milta Little, DO, CMD Milta Little, DO, CMD, is an Associate Professor of Medicine at St. Louis University in the Division of Geriatric Medicine. She is board certified in General Internal Medicine, with added qualifications in Geriatric Medicine. She serves the division as Program Director of the Geriatric Medicine Fellowship. Her primary scholarly interest is interprofessional health education to improve the care of the frail geriatric patient. Dr. Little has been on the St. Louis Magazine Best Doctor list since 2013. She is a Certified Medical Director and as such, has been a medical director at a number of Skilled Nursing Facilities. She served AMDA on the board of directors from 2012-2016 and from 2017 to present.   References: M. Little, "TREATING AND PREVENTING CLOSTRIDIUM DIFFICILE INFECTION IN LONG-TERM CARE FACILITIES", Managed Healthcare Connect, Nov, 2018 C. McDonald, et. al."Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)", Clinical Infectious Diseases, Volume 66, Issue 7, 19 March 2018 Leffler, DA and Lamont JT, "Clostridium difficile Infection”, New England Journal of Medicine, 2015 Lessa, FC, et. al., “Burden of Clostridium difficile Infection in the United States", New England Journal of Medicine, 2015

"Outbreak Communications," produced by the Society for Healthcare Epidemiology of America (SHEA), discusses lessons learned in communicating with healthcare personnel, patients, and others during recent infectious diseases outbreaks. Moderator: Judith Guzman-Cottrill,DO, Professor of Pediatrics at Oregon Health & Science University and consultant for the Oregon Health Authority’s HAI Program, where she serves as the Medical Director for Ebola and Emerging Pathogen Preparedness. Speaker: Zachary Rubin, MD, Specialist in Infectious Diseases and Medical Director of Clinical Epidemiology and Infection Prevention at the University of California, Los Angeles. Before coming to UCLA in 2006, he was a guest researcher at the CDC in the Division of Healthcare Quality Promotion for the last 2 years of his ID fellowship at Emory.

"HICS: The Insider's Perspective," produced by the Society for Healthcare Epidemiology of America (SHEA), discusses the Hospital Incident Command System - what HICS is, who's involved, when to activate, and why it's important. Moderator: Judith Guzman-Cottrill,DO, Professor of Pediatrics at Oregon Health & Science University and consultant for the Oregon Health Authority’s HAI Program, where she serves as the Medical Director for Ebola and Emerging Pathogen Preparedness. Panelists: Kristina Spurgeon, MPH, Emergency Manager at UC Davis Health, with experience including a decade at Kaiser Permanente specializing in emergency management. Pritish Tosh, MD, infectious diseases physician and the medical director for Emergency Management at Mayo Clinic in Rochester, MN. His prior training includes the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC) and as a fellow with the Center for Infectious Diseases Research and Policy (CIDRAP) at the University of Minnesota.

A few weeks ago, a post on Clay Smith’s Journal Feedabout the new IDSA C diff guidelines caught my attention (specifically, that metronidazole is no longer recommended as first line therapy). Whuut? I tweeted this and @medquestioningtweeted back, "Need to dig to see why they dropped metro in the bucket." Yes, @medquestioning, my thoughts exactly.   Mentioned in this episode ERcast 2.0launches May 1, 2018 To sign up for the new site and 1 year of free CME, click here Essentials of Emergency Medicineis just around the corner. If you can't make it to Vegas, the digital live stream is pretty sweet.     New IDSA C Diff Guideline Treatment Recommendations   Initial Episode, Non Severe (WBC ≤ 15k, creatinine < 1.5) First Line Vancomycin 125 mg PO QID for 10 days Fidaxomicin 200mg PO  BID for 10 days Second line Metronidazole 500mg TID PO for 10 days   Initial Episode, Severe (WBC >15k, creatinine >1.5) Vancomycin 125 mg PO QID for 10 days Fidaxomicin 200mg PO  BID for 10 days   Initial Episode, Fulminant (Hypotension or shock, ileus, megacolon) Vancomycin 500 mg 4 times per day by mouth or by nasogastric tube. If ileus, consider adding rectal instillation of vancomycin. Intravenously administered metronidazole (500 mg every 8 hours) should be administered together with oral or rectal vancomycin, particularly if ileus is present   First Recurrence • Vancomycin 125 mg given 4 times daily for 10 days if metronidazole was used for the initial episode, OR • Use a prolonged tapered and pulsed vancomycin regimen if a standard regimen was used for the initial episode (eg, 125 mg 4 times per day for 10–14 days, 2 times per day for a week, once per day for a week, and then every 2 or 3 days for 2–8 weeks), OR •  Fidaxomicin 200 mg given twice daily for 10 days if Vancomycin was used for the initial episode     Photo Credit Photo by Gabor Monori on Unsplash     The Guidelines McDonald, L. Clifford, et al. "Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)." Clinical Infectious Diseases66.7 (2018): e1-e48. PMID:29462280 Original Studies Teasley, DavidG, et al. "Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis." The Lancet322.8358 (1983): 1043-1046. PMID:6138597 Wenisch, C., et al. "Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile—associated diarrhea." Clinical infectious diseases22.5 (1996): 813-818. PMID:8722937 New Evidence Favoring Vancomycin Zar, Fred A., et al. "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile–associated diarrhea, stratified by disease severity." Clinical Infectious Diseases45.3 (2007): 302-307. PMID:17599306 Johnson, Stuart, et al. "Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials." Clinical Infectious Diseases 59.3 (2014): 345-354. PMID: 24799326 CDC C. Diff Statistics   New York Times article on the association of the rise of new sweeteners and the rise of C. diff. The Germs That Love Diet Soda

The Infectious Diseases Society of America's Guideline Update provides concise summaries of the most important IDSA guidelines. This podcast discusses the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) published in Clinical Infectious Diseases. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College,Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health L. Clifford McDonald, MD, Associate Director for Science, Division of Healthcare Quality Promotion, Centers for Disease Control, Atlanta, Georgia

The last podcast in the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on how to impact antibiotic prescribing practices using Antimicrobial Stewardship Interventions targeting providers and patients in the outpatient setting. Panelists: Debra Palazzi, MD, MEd, Associate Professor of Pediatrics in the Infectious Diseases Section at Baylor College of Medicine, and the Medical Director of the Antimicrobial Stewardship Program at Texas Children’s Hospital; and Ellen Wald, MD, Professor and Chair of the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health and an internationally recognized expert on the diagnosis and treatment of pediatric infectious diseases.

The third podcast of the series “Stewardship: Practical Approaches and Applications”, produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on the leading cause of antibiotic use with UTI over diagnosis in the Adult and Pediatric populations.

The second podcast of the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on integrating technological and sociobehavioral approaches to diagnostic stewardship, with a specific focus on improving blood culture ordering practices.

The first podcast of the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on demonstrating how to impact the rates of Clostridium Difficile infections using antimicrobial stewardship interventions targeting providers in various practice settings. Panelists: Libby S Dodds-Ashley, PharmD, MHS with the Duke Antimicrobial Stewardship Outreach Network, and Dr. Larissa May, MD, MSHS, MSPH, an Associate Professor and Director of Emergency Department Antibiotic Stewardship at UC Davis Health System.

Host: Linda Bernstein, Pharm.D. In this premiere edition of The Pharmacy Report®, host Dr. Linda Bernstein focuses on the growing threat of antimicrobial drug resistance. Top news stories include the CDC's "Threat Report 2013," and FDA drug and new indication approval updates. In this week's Movers and Shakers segment, Joseph Guglielmo, PharmD, Dean of the UCSF School of Pharmacy and a clinical pharmacist specialist in infectious disease will address antimicrobial stewardship and the role of the physician and pharmacist in these multidisciplinary programs. References mentioned in this segment: Centers for Disease Control and Prevention: Threat Report 2013 Antibioitic Resistance Threats in the United States, 2013 Antimicrobial stewardship guidelines Dellit TH, Owens RC, McGowan Jr JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, and Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis. 2007 Jan 15;44(2):159-77 IDSA REPORT: Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, ...